echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > In 2020, what are the key words for the development of Chinese Herbal Pieces industry?

    In 2020, what are the key words for the development of Chinese Herbal Pieces industry?

    • Last Update: 2020-02-10
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    [pharmaceutical network market analysis] Chinese herbal pieces are processed and can be directly used in clinical Chinese medicine At present, with the strengthening of the industry centralized regulation, the Chinese herbal medicine industry is facing the situation of both opportunities and challenges, and the key words of the industry development are gradually clear, namely: standardized operation and safe drug use Opportunities and challenges coexist on December 1, 2019 With the formal implementation of the new drug management law, the traditional Chinese medicine industry is facing opportunities and challenges In terms of opportunities, with the support of policies, the upgrading of people's consumption level and the aggravation of aging and other factors, the demand for traditional Chinese medicine medical consumption is growing According to the data, the market scale of Chinese herbal medicine in 2018 has exceeded 120 billion yuan It is expected to reach 170.8 billion yuan in 2022, more than 200 billion yuan in 2024, with an average compound annual growth of nearly 10% The market performance of Chinese herbal pieces is strong The market scale increased from 24.2 billion yuan in 2007 to nearly 200 billion yuan in 2016, with an average annual growth rate of 26% According to the 13th five year plan, it is expected that the market scale of Chinese Herbal Pieces in 2020 will double that in 2016, reaching 391.2 billion yuan In terms of challenges, in the field of production and processing of Chinese herbal pieces, there are still serious practical problems such as scattered, disordered, poor, adulterated, fake, inferior and so on, which affect the overall product quality The newly revised "Drug Administration Law" clearly raises the starting point of the penalty amount of fake and inferior Chinese herbal pieces, for example, it is clear in Article 117: "if the Chinese herbal pieces produced and sold do not meet the drug standards and do not affect the safety and effectiveness, it shall be ordered to make corrections within a time limit and given a warning; it may be imposed a fine of more than 100000 yuan but less than 500000 yuan." It can be seen that, while seizing the opportunity for development, the Chinese Herbal Pieces industry is also facing more stringent regulatory pressure In the face of opportunities and challenges, how should the Chinese herbal medicine industry develop in 2020? Some industry figures pointed out that with the promotion of centralized treatment of Chinese herbal pieces, standardized operation and safe drug use will become the key words of the current retail industry of Chinese herbal pieces Pharmaceutical enterprises shall produce according to GMP requirements and regulations to ensure product quality and safety The Pharmacopoeia of 2020 edition also has new regulations on Chinese herbal pieces Among them, we should "focus on improving and standardizing the processing methods of Chinese Herbal Pieces" The industry believes that this will be conducive to guiding the standardized production and operation of Chinese Herbal Pieces enterprises, further improving the quality control level of Chinese herbal pieces, ensuring the drug safety of the public, and promoting the high-quality development of Chinese herbal medicine In fact, from the perspective of the quality sampling of Chinese herbal medicines and pieces of Chinese herbal medicines, the qualification rate of Chinese herbal medicines and pieces of Chinese herbal medicines in 2013-2018 continued to rise, from 64% in 2013 to 88% in 2018, and the quality steadily improved At present, with the continuous improvement of the concentration of Chinese Herbal Pieces industry, the trend of the strong is becoming more and more obvious Many enterprises have exited due to capital pressure and sales problems, and some circulation giants have entered the market strongly For example, as a strategic business segment of Jiuzhoutong group and its Chinese medicine industry platform company, Jiuxin Chinese medicine group is committed to working with various chain enterprises to create a reassuring drug environment In general, in the process of industry standardization, only by standardizing operation and improving product quality can competitive enterprises go further.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.